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Incidentally detected stenoses proximal to
grafts originating below the common
femoral artery: Do they affect graft patency
or warrant repair in asymptomatic patients?
Gerald S. Treiman, MD, Amir Ashrafi, and Peter F. Lawrence, MD, Salt Lake
City, Utah
Objective: Stenoses in infrageniculate arteries proximal to a lower extremity vein graft
may reduce flow velocity through the bypass graft and are thought to predispose to graft
occlusion. Repair of these lesions has been recommended to preserve graft function. This
study was undertaken to better define the natural history of grafts below inflow lesions
and to evaluate the necessity of repair to preserve graft patency.
Methods: From 1994 through 1999, patients undergoing lower extremity vein grafts by
a single surgeon at a university hospital and an affiliated teaching hospital were placed
in a prospective protocol for proximal infrageniculate native artery and graft surveillance
through use of duplex scanning. The records of those patients with grafts originating
distal to the common femoral artery were evaluated; they form the basis for this report.
Arteriograms were obtained before bypass grafting, and no patient had a stenosis greater
than 50% diameter reduction proximal to the graft origin. Follow-up scans were
obtained from the common femoral artery through the graft and outflow artery. The
peak systolic velocity and velocity ratio in an infrageniculate native artery proximal to
the graft origin were recorded, as were the location and the time interval since the bypass
graft. Repair of these proximal lesions was not performed during the course of this
study. Revision of the bypass graft or its anastomoses was undertaken according to
preestablished duplex scan criteria.
Results: During this time, 288 autogenous infrainguinal bypass grafts were performed,
of which 159 originated below the common femoral artery; of these, 74 were from the
superficial femoral artery, 29 from the profunda femoris artery, 49 from the popliteal
artery, and 7 from a tibial artery. The maximum peak systolic velocity proximal to the
graft origin was more than 250 in 38 arteries (25%) and more than 300 in 26 arter-
ies (16%). The velocity ratio was 3.0 or more in 32 arteries at the same location as the
peak systolic velocity and 3.5 or more in 23 arteries (15%), confirming hemodynami-
cally significant stenoses at these sites. The location of peak systolic velocity was the
common femoral artery in 81 patients (51%), the superficial femoral artery in 50
(31%), the popliteal artery in 22 (14%), and a tibial artery in 6 (4%). Follow-up
ranged from 8 to 60 months (mean, 35 months). During follow-up, 19 patients died,
18 with patent grafts. Overall, nine grafts occluded. One of the occluded grafts had a
velocity ratio greater than 3.0; this may have contributed to graft thrombosis. The
other occlusions resulted from an unrepaired graft lesion in 2 patients, graft infection
in 2 patients, and graft ligation necessitated by below-knee amputation in 2 patients.
No cause for the occlusion could be identified in two of the grafts (neither had evi-
dence of proximal arterial stenosis). Assisted primary patency rates were 95% and 91%
at 3 and 5 years, respectively.
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Hemodynamically significant lesions in infra-
geniculate arteries proximal to the origin of lower
extremity vein grafts are thought to predispose to
graft occlusion. Identification and repair of these
lesions have therefore been recommended to pre-
serve graft function. However, the natural history of
grafts below these lesions is not well defined, and no
studies have routinely followed these grafts without
intervention and evaluated graft patency.
Operative or endovascular treatment of proximal
lesions, often with antecedent arteriography, is associ-
ated with significant cost and, in our experience, occa-
sionally with significant morbidity. Iatrogenic arterial
dissection or embolization may result in graft throm-
bosis, and infection may predispose to eventual graft
rupture. In addition, routine surveillance of these
proximal arteries with duplex scanning represents a
time and cost burden to vascular laboratories evaluat-
ing significant numbers of grafts. Omission of surveil-
lance and repair offers the potential to reduce the cost
and morbidity of graft maintenance, but only if graft
patency is not jeopardized. The current study was
therefore undertaken to better define the natural his-
tory of grafts below infrageniculate native arteries that
develop significant stenoses and to determine whether
correction of these proximal arterial lesions can be
safely omitted without affecting graft patency.
METHODS AND MATERIALS
From 1994 through 1999, patients undergoing
infrainguinal bypass grafting through use of reversed
saphenous vein at the University of Utah Medical
Center and an affiliated teaching hospital staffed by
the same surgeon were placed in a prospective pro-
tocol in which duplex scanning was used to evaluate
the bypass graft and the proximal infrageniculate
native arterial circulation. Preoperative evaluation
included physical examination, ankle-brachial
indices (ABIs) with arterial waveforms, and arteriog-
raphy in all patients. Toe pressures were obtained in
individuals with calcified or noncompressible arter-
ies. Patients underwent arteriography before arterial
reconstruction, and no patient had a stenosis proxi-
mal to the graft origin of greater than 50% diameter
reduction on the basis of review of arteriograms by
the attending vascular surgeon and a radiologist.
Grafts were placed with the proximal anastomosis at
the most distal site possible without a proximal
lesion resulting in stenosis greater than 50%. This
approach was used to minimize the length of requi-
site vein, minimize size discrepancy between the
inflow artery and the reversed saphenous vein, and
avoid dissection through scarred or previously dis-
sected tissue. Most grafts were placed subcutaneous-
ly to allow for ease of surveillance and repair.
A completion duplex scan was obtained either
intraoperatively or immediately postoperatively to
ensure technical adequacy. These scans evaluated
infrageniculate arteries and bypass grafts but did not
routinely evaluate the aortoiliac segments. After
surgery, patients underwent duplex scanning, physi-
cal examination, and ABIs every 3 months for the
first 2 years, then every 6 months thereafter.
Postoperative duplex scans examined all infra-
inguinal arteries proximal to the graft origin,
beginning with the common femoral artery and
proceeding distally to include the bypass graft,
both anastomoses, and the distal runoff artery.
The iliac arteries were examined when common
femoral waveforms suggested a hemodynamically
significant iliac stenosis.
The duplex scan findings suggestive of possible
iliac artery stenosis included a rounded upstroke on
the waveform tracing and a clearly prolonged
upstroke acceleration time. Each study determined
the highest peak systolic velocity (PSV) and velocity
ratio (VR) from a native infrageniculate artery proxi-
mal to the graft origin, as well as the location and
time interval from the bypass graft to the highest
PSV and VR. The VR was calculated by comparing
the highest PSV in a native artery with the velocity in
the same artery just proximal to the stenosis. In addi-
tion, the distal graft velocity and PSV within the
bypass graft were recorded at each evaluation. The
distal graft velocity was measured just proximal to the
distal anastomosis because all grafts were reversed
vein bypass grafts with the largest diameter segment
placed distally. Appropriate angle correction was used
in an attempt to ensure accurate velocities. Vein graft
revision was performed for a VR greater than 3.0
involving the graft or its anastomoses. An elevated
PSV without an elevated VR was not used as the basis
Conclusions: For grafts originating distal to the common femoral artery, stenoses proxi-
mal to the graft do not affect bypass graft patency and do not require repair to prevent
graft occlusion. Surveillance of these lesions may therefore be unnecessary, inasmuch as
the repair of proximal lesions should not be undertaken to preserve graft function. (J
Vasc Surg 2000;32:1180-9.)
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for repair. Arteriograms were not routinely obtained
before vein graft revision. In contrast to vein graft
stenoses, stenoses in native infrageniculate arteries
proximal to the graft origin, as determined by a PSV
or VR elevated in comparison with the adjacent prox-
imal arterial segment, were not treated to preserve
graft patency. Therefore, these lesions were not rou-
tinely evaluated with arteriography or repaired in an
attempt to prevent graft occlusion.
Patients with recurrent symptoms and individuals
in whom no graft was present were managed in a
similar manner. These few patients with recurrent
symptoms and arterial insufficiency in the affected
extremity despite a patent bypass were treated for
limb preservation, not for graft salvage. Arterial
insufficiency was determined by a reduction in ABI
of more than 0.15 and either a change in distal arte-
rial waveform configuration or a decrease in midgraft
upstroke acceleration time. The presence of an infra-
geniculate inflow lesion without symptoms of arteri-
al insufficiency was not evaluated with arteriography
or treated. The proximal lesions were followed with
serial duplex scans to better determine their natural
history and effect on bypass graft patency.
Vascular laboratory technique. Studies were
performed by a registered vascular technologist who
used either an Acuson XP 128 ART (Acuson,
Mountain View, Calif) or ATL 3000 (ATL, Bothell,
Wash) scanner with a 7.5-MHz or 5.0-MHz probe
for both the B-mode and the Doppler component.
All studies were interpreted by a vascular surgeon
with Registered Vascular Technologist (RVT) certi-
fication. Previously, we and others have validated the
ability of duplex scanning to determine a hemody-
namically significant arterial stenosis. At one institu-
tion, duplex scan evaluation of femoral arteries has
been correlated with arteriography. At both institu-
tions, selected patients undergoing both arteriogra-
phy and duplex scanning have had the findings
reviewed with good correlation, and no patient has
been identified with a duplex scan–identified steno-
sis that was not confirmed by arteriography or at
operation. Correlation of duplex scan velocity crite-
ria with arteriography has been performed as part of
Intersocietal Commission for the Accreditation of
Vascular Laboratories (ICAVL) accreditation,
although this has not been specifically done for
proximal infrageniculate native arteries.
Data analysis. The indication for the initial pro-
cedure, details of the initial operation, date and loca-
tion of any revisions, patient cardiovascular risk fac-
tors and demographic information, graft and native
artery hemodynamic parameters, and outcome were
prospectively recorded and entered into a computer-
Fig 1. Interval to PSV from bypass graft (in months).
Table I. PSV and VR in proximal artery: 159 grafts
PSV* (cm/s) No. of grafts (%) VR No. of grafts




> 250 38 (24) > 2.5 28
> 3.0 24
> 3.5 21
> 300 26 (16) > 3.0 16
> 3.5 16
*Range, 21-516.
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ized database (Filemaker Pro 4.0, Microsoft,
Redmond, Wash). Statistical analysis to determine
the relationship between inflow stenosis, as deter-
mined by PSV and VR, and subsequent graft paten-
cy and limb salvage was performed through use of
an independent t test. Correlation of discrete cutoff
levels for PSV (> 200, > 250, > 300 cm/s) and VR
(> 2.0, > 2.5, > 3.0) with success or failure was
determined through use of the Fisher t test. Results
were reported in accordance with the suggested
reporting standards for lower extremity arterial pro-
cedures as defined by the Society for Vascular
Surgery and the North American Chapter of the
International Society for Cardiovascular Surgery.1
The life table method was used to analyze graft
patency. Each affected lower extremity was analyzed
separately. The assisted primary patency reflected
bypass grafts that have remained patent after one or
more revisions.
Demographic information. From 1994
through 1999, 288 patients underwent infrainguinal
bypass grafting. One hundred fifty-nine of these
grafts were composed of reversed saphenous vein
and originated distal to the common femoral artery;
they form the basis of this report. The 159 patients
(125 male, 34 female) ranged in age from 32 to 91
years (mean, 61 years). Cardiovascular risk factors
included a history of cigarette use in 122 patients
(77%), hypertension (defined as requiring medica-
tion for blood pressure control) in 84 (53%), symp-
tomatic cardiac disease in 71 (45%), diabetes in 69
(43%), renal insufficiency (defined as a creatinine
level > 1.5) in 66 (42%), and hyperlipidemia in 38
(24%). Forty-seven patients had undergone a previ-
ous arterial reconstruction, including a bypass graft
on the contralateral limb (19), an inflow procedure
above the inguinal ligament of the operated lower
extremity (14), or a previous ipsilateral infrainguinal
bypass graft (14). No patient in this study under-
went a previous iliac or femoral endarterectomy.
Patients undergoing prior aortoiliac reconstructions
were included in this review, inasmuch as our study
focused on infrageniculate native arterial stenoses.
Initial operation. The indication for the initial
operation was gangrene or a nonhealing wound in
85 patients (53%), ischemic rest pain in 40 (25%),
disabling intermittent claudication in 28 (18%), and
a popliteal aneurysm in 6 (4%). The inflow artery
was the superficial femoral artery (SFA) in 74
patients (47%), the profunda femoris artery in 29
(18%), the popliteal artery in 49 (31%), and a tibial
or peroneal artery in 7 (4%). The outflow artery was
the popliteal in 85 (53%), a tibial in 51 (32%), and a
pedal in 23 (15%). The mean preoperative ABI was
0.49, although 12 patients had calcified tibial arter-
ies that were associated with artificially elevated
ABIs. The 12 patients with artificially elevated or
inaccurate ABIs did not have their ABI values
included in the analysis of ABI data.
RESULTS
Hemodynamic parameters. In the 159 patients,
the value for the highest PSV identified postopera-
tively in an infrageniculate artery proximal to the
graft, as determined by sequential duplex scan mea-
surements, ranged from 21 to 516 cm/s; the highest
PSV was greater than 250 cm/s in 38 grafts (25%)
and greater than 300 cm/s in 26 grafts (16%). No
threshold value of PSV was used to determine that
proximal revision was to be performed. One hundred
fifty-one patients (94%) had the highest PSV and VR
in a proximal artery within 12 months of graft place-
ment (Fig 1); only eight patients had the maximum
PSV more than 12 months after bypass grafting.
However, this reflects the greater number of duplex
scans obtained during the first 24 months as well as
the varying duration of follow-up. No patient had
the highest PSV identified on the completion duplex
scan. This suggests that the inflow stenosis developed
during follow-up rather than representing a residual
lesion. In addition, as noted previously, no patient
had a proximal arterial stenosis greater than 50%
according to preoperative arteriography.
The number and percent of patients with an ele-
vated VR for each PSV are listed in Table I. Each of
30 arteries had a PSV greater than 200 cm/s and a
VR greater than 3.0; 16 of these arteries had PSVs
greater than 300 cm/s and VRs greater than 3.0.
None of these 30 patients underwent routine arteri-
ography. Values for the VR proximal to the graft
ranged from 0.3 to 6.8 at the site of maximum
velocity elevation (PSV). The VR was greater than
2.0 in 64 patients (39%), greater than 2.5 in 45
(27%), greater than 3.0 in 32 (20%), and greater
than 3.5 in 23 (14%). The 32 patients with a VR
greater than 3.0 would have undergone revision if
the lesion had been in the graft and not the proximal
native artery. Ninety-five patients did not have a VR
greater than 2.5, and 111 did not have a PSV greater
than 250 cm/s in any proximal infrainguinal artery.
With a VR greater than 2.0 indicating a 50% diame-
ter reduction, 97 patients did not have a stenosis in
a native artery reaching this level. With a VR greater
than 3.0 indicating a 70% diameter reduction (a
hemodynamically significant lesion), 127 patients
did not have an infrageniculate proximal arterial
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stenosis. Each patient with a VR greater than 2.0
had the elevated VR at the site of the maximum PSV.
Each of 16 grafts (10% of the study grafts) had a
VR greater than 3.0 with a PSV greater than 300
cm/s. In all cases, these values were not present on
the initial postoperative duplex scans. Five lesions
were first detected at 3 months, 5 at 6 months, 3 at
9 months, 2 at 12 months, and 1 at 15 months,
which suggests that these represent stenoses that
developed rather than residual lesions. The progres-
sion of proximal stenosis in these patients was not
associated with a change in distal graft velocity or
graft velocity waveform. The distal graft velocity val-
ues in these patients ranged from 31 to 158 cm/s.
Seven lesions occurred in the SFA, 7 in the common
femoral artery, and 2 in the above-knee popliteal
artery. Twelve (75%) of the 16 showed progression
on serial scans; nine of these patients eventually
underwent revision of the graft for a separate lesion
within the bypass graft.
The location of the maximum PSV and VR was
the common femoral artery in 81 patients, the SFA
in 50, the popliteal artery in 22, and a tibial artery in
6. Most velocity elevations were in the common
femoral artery, which reflects the evaluation of this
vessel in all patients. In patients with grafts originat-
ing from the proximal SFA or deep femoral artery,
the common femoral was usually the only inflow
artery evaluated above the proximal anastomosis.
For grafts originating from the popliteal or a tibial
artery, the SFA was the more frequent site of PSV
and VR elevation; this is a reflection of its smaller
diameter, greater disposition for atherosclerotic dis-
ease, and greater length in comparison with the
common femoral artery.
Follow-up. Follow-up for the 159 patients ranged
from 8 to 60 months (mean, 35 months). The mean
duration of follow-up after detection of the highest
PSV and VR was 28 months. One hundred forty
patients are alive; 19 patients died, 18 with patent
grafts. Thirty-five (20%) of the 159 patients under-
went revision of the vein graft during the course of this
study. The revision performed was a patch angioplasty
in 27 cases and an interposition graft in eight cases.
The length of the interval from the initial operation to
the revision was 3 months in 5 patients, 6 months in
7, 7 months in 4, 8 months in 3, 9 months in 5, 12
months in 8, and 15 months in 3. None of these
patients had creation of a new proximal anastomotic
site. Nine of these patients had a PSV greater than 250
and a VR greater than 3.0 (severe stenosis). Revision
of an intrinsic graft stenosis was associated with an
improvement in distal graft velocity (mean increase, 43
cm/s) and ABI (0.33). In accordance with the proto-
col, no patient underwent repair of a proximal native
arterial stenosis. Of the 35 patients undergoing graft
Table II. Life table data analysis for assisted primary patency in 159 grafts originating distal to common
femoral artery
Withdrawn patent
Interval No. of grafts at Because of Because of Interval Cumulative
(mo) risk at start Failed duration death patency rate patency (%) SE
0-1 159 1 0 0 .993 100 0.00
1-2 158 0 0 1 1.0 99.3 0.66
3-5 157 1 0 5 .994 99.3 0.66
6-8 151 0 0 0 1.0 98.7 0.89
9-11 151 1 1 1 .993 98.7 0.89
12-14 148 0 0 1 1.0 98.0 1.10
15-17 147 0 4 2 1.0 98.0 1.10
18-20 141 2 10 2 .985 98.0 1.10
21-23 127 1 10 0 .992 96.5 1.42
24-26 116 1 10 2 .991 95.8 1.56
27-29 103 0 12 0 1.0 94.9 1.70
30-32 91 0 8 2 1.0 94.9 1.70
33-35 81 0 6 1 1.0 94.9 1.70
36-38 74 0 7 0 1.0 94.9 1.70
39-41 67 1 11 1 .984 94.9 1.70
42-44 54 1 13 0 .980 93.4 1.90
45-47 40 0 10 0 1.0 91.5 2.11
48-50 30 0 6 0 1.0 91.5 2.11
51-53 24 0 5 0 1.0 91.5 2.11
54-56 19 0 10 0 1.0 91.5 2.11
57-60 9 0 9 0 1.0 91.5 2.11
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repair, 20 had PSVs greater than 150 in the proximal
infrageniculate inflow artery. The proximal stenosis
was not revised in any of these patients. All 20 of these
grafts remained patent during follow-up.
During follow-up, nine grafts (6%) occluded. Five
grafts that occluded had no hemodynamic evidence
of an inflow stenosis, as determined by PSV or VR,
before or at the time of graft thrombosis. Four of the
nine grafts had an elevated PSV greater than 200
cm/s or a VR greater than 2.0 in an artery proximal
to the bypass graft identified before graft thrombosis.
One of these four grafts, with a PSV of 201 cm/s and
a VR of 2.2, occluded and was excised because of
graft infection. The other three grafts occluding with
an inflow stenosis had PSVs of 106, 250, and 316
cm/s, with VRs of 1.8, 3.0, and 4.0, respectively.
The etiology for graft occlusion in 6 of these 9
patients was as follows: graft infection in 2 patients;
unrepaired midgraft lesion as determined by elevat-
ed VR greater than 3.0 in 2 patients; graft ligation
necessitated by below-knee amputation to control
foot infection despite a patent bypass in 2 patients.
Two patients had normal hemodynamic parameters
in both the inflow artery and the graft. In one
patient, inflow stenosis may have contributed to
graft thrombosis, inasmuch as the PSV and VR were
elevated in the native artery; this patient had no
reduction in ABI, no recurrent symptoms, and no
reduction in distal graft velocity to indicate that the
graft was at risk for occluding.
For all 159 patients, the assisted primary paten-
cies were 98%, 95%, and 91% at 1, 3, and 5 years,
respectively (Table II and Fig 2). One patient under-
went thrombolysis and revision after graft occlusion;
the graft subsequently reoccluded. The maximum
PSV and VR in the native proximal artery were not
statistically significant in predicting either graft
occlusion or limb loss (P > .05; Table III).
Patients were then stratified on the basis of the
presence of an infrageniculate proximal arterial
stenosis. Graft patency was calculated separately for
the 50 patients with PSVs greater than 150 cm/s
and VRs greater than 2.0 (proximal stenosis) and for
the other 109 patients without proximal arterial
stenosis. By life table analysis, assisted primary
patencies were found to be 100%, 95%, and 92% at
1, 3, and 5 years for patients with stenosis and 99%,
93%, and 90% at the same intervals for patients with-
out stenosis (Tables IV and V). During the course of
this study, two patients had recurrent symptoms and
hemodynamic deterioration despite a patent bypass
graft. Both had claudication and desired treatment.
Arteriography demonstrated severe aortoiliac disease
in both patients, and both underwent aortofemoral
bypass grafting. These procedures were performed 4
and 5 years after the distal bypass graft. Patients with
significant inflow disease before lower extremity
bypass grafting had their proximal (inflow) lesions
corrected first, and these are included among the
Fig 2. Life table plot of assisted primary patency.
Table III. Correlation of graft occlusion with dif-
ferent levels of PSV and VR
No. of grafts
Patent Occluded P value
PSV
≥ 250 28 1 .4066
≥ 300 17 1 .3955
VR
≥ 2.5 43 2 .3257
≥ 3.0 30 2 .2842
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patients listed with “prior arterial procedures.” No
patient had a hemodynamically significant common
femoral artery or SFA lesion in conjunction with
recurrent symptoms during the course of this review.
DISCUSSION
Stenoses in infrageniculate arteries proximal to
grafts originating below the common femoral artery
are frequently identified on the basis of serial duplex
scan examinations. In our study, each of 30 proximal
arteries (19% of extremities) had a PSV greater than
200 cm/s and a VR greater than 3.0, some lesions
being greater than 80% to 90%.
Calligaro et al2 noted that 28% of grafts (19
patients) developed inflow lesions, whereas a
University of Oregon study found that 18% of grafts
(37 of 205 patients) developed inflow stenoses.3
However, Mills et al4 found that only 5% of grafts
developed inflow lesions; this is similar to the find-
ings of Mattos et al,5 who reported a 3.6% incidence,
and other investigators.6-8 Criteria for identification
of an inflow lesion, however, have often been
unspecified or differed between reports. In addition,
the number of proximal lesions invariably increases
with longer follow-up.
Several reports have found that stenoses in inflow
arteries proximal to infrainguinal vein grafts rarely
result in graft thrombosis. Most occlusions result
from lesions within the bypass graft or its anasto-
moses.5,9,10 At the University of Arizona, Westerband
et al9 prospectively evaluated 101 grafts and found
that no inflow lesions resulted in graft occlusion; sev-
eral grafts remained patent from collateral blood flow
despite complete proximal inflow artery or bypass
occlusion. Taylor et al11 reported on 450 grafts; they
too found no occlusions resulting from inflow lesions,
the mean follow-up being 22 months (range, 1-22
months). Donaldson et al12 reported on 455 grafts
with a mean follow-up of 18 months, defining graft
failure as stenosis greater than 50%; only two of 92
failures resulted from inflow lesions. Grigg et al,13
reporting on 75 grafts, noted no graft occlusions
resulting from extrinsic lesions. Caps et al14 and
Mattos et al,5 in studies of infrainguinal vein grafts
with duplex scanning, found that no occlusions
resulted from inflow disease. Dougherty et al,15 in a
study not limited to infrainguinal vein grafts, also
found that progression of proximal disease did not
result in any graft occlusions.
Smith concluded that inflow stenosis does not
invariably lead to graft occlusion and used the term
“pseudo-occlusion” to define a graft that is thought
to be occluded but in fact is patent below an inflow
occlusion.11 Fourteen grafts had proximal lesions
identified on arteriography; all remained patent.11
Idu et al16 reported only one graft occlusion result-
Table IV. Life table data analysis for assisted primary patency in 50 grafts originating distal to common
femoral artery with proximal arterial stenosis (PSV > 150 cm/s and VR > 2.0)
Withdrawn patent
Interval No. of grafts Because Because Interval Cumulative
(mo) at risk at start Failed of duration of death patency rate patency (%)
0-1 50 0 0 0 1.0 1.0
1-2 50 0 0 0 1.0 1.0
3-4 50 0 0 0 1.0 1.0
4-6 50 0 0 0 1.0 1.0
7-9 50 0 0 0 1.0 1.0
10-12 50 0 0 0 1.0 1.0
13-15 50 0 0 0 1.0 1.0
16-18 50 0 0 1 1.0 1.0
19-21 49 0 2 1 1.0 1.0
22-24 46 1 2 0 .978 .978
25-27 43 0 2 0 1.0 .978
28-30 41 1 0 0 .976 .954
31-33 40 0 1 0 1.0 .954
34-36 39 0 4 0 1.0 .954
37-39 35 1 4 1 .970 .925
40-42 29 0 5 0 1.0 .925
43-45 24 0 3 0 1.0 .925
46-48 21 0 7 0 1.0 .925
49-52 14 0 2 0 1.0 .925
53-55 12 0 4 0 1.0 .925
56-60 8 0 8 0 1.0 .925
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ing from inflow obstruction, and Mattos,5 in an
early report on 170 limbs, found that proximal
lesions did not result in any graft occlusions.
These studies and our own experience prompt us
to question the traditional view that a critical blood
flow velocity in the inflow artery is necessary for
graft patency. Whether there is an absolute threshold
for blood flow velocity cannot be determined. Grafts
originating from tibial or even pedal arteries, often
with very low velocity in the inflow artery, have
patency equivalent to grafts from more proximal ves-
sels. Large-diameter grafts and grafts to distal arter-
ies frequently have PSVs below 20 or even 15 cm/s,
yet they usually remain patent.17,18 In addition, our
results are supported by other studies on graft revi-
sion, which have found that low global graft veloci-
ty (or distal graft velocity) is not a reliable indicator
of impending graft occlusion and should not neces-
sarily be the basis for graft revision.12,19
Almost all of the studies described in the preced-
ing paragraphs as evaluating the effect of proximal
arterial stenosis on patency reviewed grafts that had
thrombosed and then attempted to determine the
etiology for graft occlusion. No study has prospec-
tively identified proximal stenoses and followed
them without intervention; the explanation for this
is the traditional view that hemodynamically signifi-
cant inflow lesions, by reducing blood flow velocity
through the graft, will lead to graft occlusion.
However, the long-term natural history of these
lesions is unknown, because most investigators rou-
tinely repaired stenoses of greater than 50%8 or
70%.9 In addition, most of these lesions are in iliac
rather than femoral, popliteal, or tibial arteries;
whether lesions in these vessels represent the same or
an increased risk has not been reported.
Because of the high patency of infrainguinal
grafts associated with a policy of routine repair of
proximal arterial stenoses, few institutions have been
willing to undertake noninterventional treatment of
these lesions. Taylor et al11 repaired 13 of the 16
inflow stenoses or occlusions after lesion identifica-
tion by arteriography and reported excellent graft
patency. Westerband et al9 noted that three inflow
lesions were associated with an ABI reduction of
greater than 0.15; all three lesions were repaired. In
that series, 96 of 101 grafts remained patent during
follow-up. Nehler et al20 have aggressively treated
inflow lesions at the University of Oregon and have
obtained greater than 90% 5-year vein graft patency.
Interestingly, despite concerns about progressive
atherosclerosis in native arteries proximal to grafts
originating from the SFA, the popliteal artery, or
tibial arteries, the patency of distal origin grafts has
been found to be equivalent to that of bypass grafts
from the common femoral artery.21 In this study, the
Table V. Life table data analysis for assisted primary patency in 109 grafts originating distal to common
femoral artery with no proximal arterial stenosis
Withdrawn patent
Interval No. of grafts at Because of Because of Interval Cumulative
(mo) risk at start Failed duration death patency rate patency rate (%)
0-1 109 0 0 0 1.0 1.0
1-3 109 0 0 0 1.0 1.0
4-6 109 0 0 0 1.0 1.0
7-9 109 1 0 6 .991 .991
10-12 102 0 1 1 1.0 .991
13-15 100 0 1 2 1.0 .991
16-18 97 1 6 0 .990 .981
19-21 90 1 8 1 .988 .970
22-24 80 1 8 2 .987 .957
25-27 69 0 9 0 1.0 .957
28-30 60 0 11 3 1.0 .957
31-33 46 0 6 0 1.0 .957
34-36 40 1 1 0 .975 .933
37-39 38 0 8 0 1.0 .933
40-42 30 1 4 0 .964 .900
43-45 25 0 9 0 1.0 .900
46-48 16 0 4 0 1.0 .900
49-51 12 0 1 0 1.0 .900
52-54 11 0 4 0 1.0 .900
55-57 7 0 3 0 1.0 .900
58-60 4 0 4 0 1.0 .900
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91% 3-year patency for grafts originating distal to
the common femoral is comparable to that for grafts
originating more proximally, and these results are
similar to reports from several other institutions.21
This suggests that the effect of these proximal arter-
ial lesions is usually not significant and that efforts to
identify these stenoses with either duplex scanning
or arteriography may not be required. In addition,
hemodynamically significant inflow lesions will often
result in recurrent symptoms,9,14 which should usu-
ally prompt diagnostic arteriography and treatment
independently of concerns about distal bypass graft
preservation. It is not surprising, given the high
patency obtained with careful follow-up and revision
of both proximal and graft lesions, that almost all
reports advocate elective repair when these lesions
are identified. Some reports recommend repair for
all lesions greater than 50%,3 whereas others do not
specify a specific threshold for revision.
On the basis of our experience and the reports of
others, we note that routine evaluation and repair of
these lesions may not be warranted. However, the
development of recurrent symptoms, especially in the
presence of a reduction in graft pulse or ABI, sug-
gests a not only hemodynamically but also clinically
significant lesion; such a lesion should be evaluated
with arteriography and repaired if indicated for treat-
ment of disabling claudication or limb-threatening
ischemia. Our study suggests, however, that prophy-
lactic repair of these lesions, in the absence of clinical
symptoms and based solely on a reduction in global
graft velocity (distal graft velocity), may not be nec-
essary to prevent graft thrombosis.
Our study does not provide follow-up beyond 5
years, and many patients have not been followed up
for more than 2 to 3 years. Longer follow-up will be
necessary to further define the natural history of these
lesions and confirm the safety of this approach.19 This
study represents only intermediate-term data on graft
patency and does not provide long-term information
on the potential effect of inflow stenoses. However, if
hemodynamically significant lesions, often present for
more than 12 to 24 months, do not lead to graft
occlusion, it is unclear that lesions present for a longer
period of time will lead to graft thrombosis.
As an additional benefit, if repair of proximal
lesions is not undertaken, then identification of
these stenoses is unnecessary and evaluation of the
proximal arterial circulation with duplex scanning
may be unnecessary. This offers a potential signifi-
cant cost benefit to institutions and vascular labora-
tories that scan significant numbers of grafts. In our
experience, routine examination of the ipsilateral
lower extremity for subcutaneously placed grafts
requires approximately 45 to 60 minutes, depending
on the location of the bypass graft and the size of the
patient’s lower extremity. For grafts originating from
the popliteal artery or a tibial artery, examination of
the common femoral artery and SFA adds 20 to 30
minutes, which almost doubles the time and cost of
the scan for the laboratory.
Because our laboratory now performs approxi-
mately 30 surveillance duplex scans each month, eval-
uation of the proximal arteries requires 9 to 10 hours
of additional technologist time and often results in
significant time delays in the vascular laboratory for
other patients waiting to be examined. The time, and
thus the cost, of the added surveillance varies depend-
ing on the technical difficulty of the study, extent of
disease, and need for physician review. At a minimum,
the additional cost to the vascular laboratory is $10 to
$15 per study (> $2000 per month), the expense
being even higher if the technologist is required to
stay overtime or if other patients experience signifi-
cant delays. There is intermittently significant cost to
the institution if another study cannot be undertaken
(because of equipment or personnel limitations) and
hospital discharge or surgery therefore needs to be
postponed or significantly delayed.
CONCLUSION
This study finds that stenoses developing in
infrageniculate arteries proximal to distal origin vein
grafts do not lead to bypass graft occlusion.
Noninterventional management of these lesions
does not jeopardize graft patency. Repair of these
lesions, though associated with excellent graft paten-
cy, does not necessarily provide additional benefit. A
policy of noninterventional treatment provides the
additional significant benefit of potentially eliminat-
ing both diagnostic or prerevision arteriography and
routine duplex scan surveillance of these vessels.
This, in turn, provides significant benefits to vascu-
lar laboratories and institutions repairing large num-
bers of grafts. In addition, eliminating operative
repair will reduce the cost and morbidity to the
patients undergoing these procedures.
We caution that this report represents only an
intermediate-term study and that our recommenda-
tions cannot be justified if the policy ultimately leads
to a higher risk of graft occlusion. Nevertheless, our
positive experience should prompt other prospective
trials of noninterventional management and should
form the basis for randomized studies comparing
graft patency both with and without repair of prox-
imal arterial lesions.
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